PA
NGD

PharVision Advisers’s New Gold Inc NGD Stock Holding History

PharVision Advisers’s Portfolio NGD Stock Details NGD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,789
Closed -$216K – 459
2025
Q4 		$216K Buy
24,789
+7,406
+43% +$55.8K 0.11% 499
2025
Q3 		$125K Buy
+17,383
New +$94.1K 0.07% 597

Other funds holding NGD

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

PharVision Advisers's NGD Position: Q1 2026 in Review

PharVision Advisers sold out of New Gold Inc (NGD) in Q1 2026, closing a stake of 24,789 shares — an estimated $216K sold.

PharVision Advisers first reported a position in NGD in Q3 2025 and held it in 2 quarters. The position peaked at $216K in Q4 2025. 2 funds tracked by Wall St. Rank hold NGD as of Q1 2026.

  • PharVision Advisers reported no remaining New Gold Inc position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 24,789 New Gold Inc shares in Q1 2026, an estimated $216K.
  • PharVision Advisers first reported a position in New Gold Inc in Q3 2025 and held it in 2 quarters.
  • PharVision Advisers's New Gold Inc position peaked at $216K in Q4 2025.
  • 2 funds tracked by Wall St. Rank held New Gold Inc as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.